{"AllianceGenome": "1549", "HGNC": "1549", "MIM": "603608", "_id": "874", "_version": 1, "accession": {"genomic": ["AB003151.1", "AP000689.1", "AP001725.1", "CH471079.2", "CP068257.2", "EF462915.1", "NC_000021.9", "NC_060945.1", "NG_052818.1"], "protein": ["AAH02812.1", "ABO43035.1", "ACI46005.1", "BAA33500.1", "BAA34207.1", "BAA89425.1", "BAA95547.1", "BAD74062.1", "BAD97149.1", "BAE45939.1", "CAA03921.1", "CAG46510.1", "EAX09747.1", "NP_001227.1", "O75828.3", "XP_011528074.1", "XP_054180884.1"], "rna": ["AB004850.1", "AB004854.1", "AB041012.1", "AB124847.1", "AJ000096.1", "AK223429.1", "BC002812.2", "CR541709.1", "FJ224313.1", "NM_001236.4", "XM_011529772.3", "XM_054324909.1"], "translation": [{"protein": "BAD97149.1", "rna": "AK223429.1"}, {"protein": "ACI46005.1", "rna": "FJ224313.1"}, {"protein": "XP_054180884.1", "rna": "XM_054324909.1"}, {"protein": "AAH02812.1", "rna": "BC002812.2"}, {"protein": "BAD74062.1", "rna": "AB041012.1"}, {"protein": "BAE45939.1", "rna": "AB124847.1"}, {"protein": "CAA03921.1", "rna": "AJ000096.1"}, {"protein": "NP_001227.1", "rna": "NM_001236.4"}, {"protein": "CAG46510.1", "rna": "CR541709.1"}, {"protein": "BAA33500.1", "rna": "AB004854.1"}, {"protein": "XP_011528074.1", "rna": "XM_011529772.3"}]}, "alias": ["HEL-S-25", "SDR21C2", "hCBR3"], "ec": ["1.1.1.184", "1.6.5.10"], "ensembl": {"gene": "ENSG00000159231", "protein": "ENSP00000290354", "transcript": "ENST00000290354", "translation": [{"protein": "ENSP00000290354", "rna": "ENST00000290354"}], "type_of_gene": "protein_coding"}, "entrezgene": "874", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.49690268524, "exp_mis": 107.89327258, "exp_syn": 55.3986283989, "lof_z": -0.635064430800489, "mis_z": 0.183331526860644, "mu_lof": 4.21328246787e-07, "mu_mis": 1.06326202857e-05, "mu_syn": 5.47615947042e-06, "n_lof": 7.0, "n_mis": 104.0, "n_syn": 34.0, "p_li": 8.02768561586313e-06, "p_null": 0.829489492058083, "p_rec": 0.170502480256301, "syn_z": 1.78232097485626}, "bp": 834, "cds_end": 37518810, "cds_start": 37507490, "n_exons": 3, "nonpsych": {"exp_lof": 4.91744744998, "exp_mis": 97.5960461778, "exp_syn": 50.0833253693, "lof_z": -0.47943653207119, "mis_z": 0.438878687828086, "mu_lof": 4.21328246787e-07, "mu_mis": 1.06326202857e-05, "mu_syn": 5.47615947042e-06, "n_lof": 6.0, "n_mis": 89.0, "n_syn": 29.0, "p_li": 5.52796204409533e-05, "p_null": 0.755205499704045, "p_rec": 0.244739220675514, "syn_z": 1.87566854110777}, "nontcga": {"exp_lof": 5.05151863672, "exp_mis": 99.2561860135, "exp_syn": 50.9611090253, "lof_z": -0.855197684851586, "mis_z": 0.262846237374024, "mu_lof": 4.21328246787e-07, "mu_mis": 1.06326202857e-05, "mu_syn": 5.47615947042e-06, "n_lof": 7.0, "n_mis": 94.0, "n_syn": 32.0, "p_li": 6.09048557847018e-06, "p_null": 0.853292660554647, "p_rec": 0.146701248959774, "syn_z": 1.68177007910402}, "transcript": "ENST00000290354.5"}, "exons": [{"cdsend": 36146512, "cdsstart": 36135192, "chr": "21", "position": [[36135078, 36135481], [36137824, 36137932], [36146075, 36146562]], "strand": 1, "transcript": "NM_001236", "txend": 36146562, "txstart": 36135078}], "exons_hg19": [{"cdsend": 37518810, "cdsstart": 37507490, "chr": "21", "position": [[37507376, 37507779], [37510122, 37510230], [37518373, 37518860]], "strand": 1, "transcript": "NM_001236", "txend": 37518860, "txstart": 37507376}], "generif": [{"pubmed": 10728668, "text": "carbonyl reductase has an important function in modifying the metastatic behavior of malignant tumors."}, {"pubmed": 11592776, "text": "Decreased Carbonyl Reductase expression in epithelial ovarian cancer is associated with RLN metastasis and poor survival"}, {"pubmed": 15537833, "text": "The common carbonyl reductase 3 (CBR3)valine244methionine polymorphism encodes for CBR3 isoforms with distinctive enzymatic properties, as revealed in DNA variation panels from 10 ethnic groups."}, {"pubmed": 18457324, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18457324, "text": "There was a trend toward an association between the CBR3 V244M polymorphism and the risk of CHf"}, {"pubmed": 18493841, "text": "These results suggested that hCBR3 and hCBR1 play distinct physiological roles."}, {"pubmed": 18551042, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 18551042, "text": "Polymorphisms in CBR3 may explain interindividual and interethnic variability of doxorubicin pharmacokinetics and pharmacodynamics."}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19016765, "text": "CBR3 polymorphisms have no significant influence on the pharmacokinetics of doxorubicin in Asian breast cancer patients."}, {"pubmed": 19016765, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19590938, "text": "identified the promoter of human CBR3. Liver samples from black donors showed higher relative CBR3 mRNA levels than samples from whites"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19671875, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19841672, "text": "analysis of the structural basis for substrate specificity in human monomeric carbonyl reductases CBR3"}, {"pubmed": 20494980, "text": "The CBR3 distal promoter contains an activating cis-regulatory element that is responsive to Trichostatin A (TSA) treatment according to promoter reporter assays in HEK 293 cells."}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20806931, "text": "CBR3 is regulated via NRF2-dependent signaling pathways, a finding and plays an important role in the cellular response to oxidative stress."}, {"pubmed": 21256830, "text": "a physiological role of CBR1, but not for CBR3, in S-nitrosoglutathione reduction and thus ultimately in regulation of NO signaling"}, {"pubmed": 22001310, "text": "Computational searches identify a conserved antioxidant response element(ARE) in the distal carbonyl reductase 3 (CBR3) promoter region."}, {"pubmed": 22124095, "text": "CBR3 polymorphisms contribute to increased cardiomyopathy risk associated with anthracycline treatment of childhood cancer."}, {"pubmed": 22360420, "text": "A protein encoded by this locus was found to be differentially expressed in postmortem brains from patients with atypical frontotemporal lobar degeneration."}, {"pubmed": 22425771, "text": "CBR3 is a novel target gene of inflammatory stimuli; elucidation of its detailed role in inflammation deserves further investigation."}, {"pubmed": 22527884, "text": "genetic polymorphism in the CBR3 gene conferred risk of type 2 diabetes and insulin resistance in Chinese. The association was probably mediated through modulation of adipogenesis."}, {"pubmed": 23182048, "text": "Variants of CBR3 and GSTP1 enzymes may be associated with changes in short-term functional cardiac parameters."}, {"pubmed": 26563179, "text": "No significant correlation between cardiotoxicity and SNPs within the CBR pathway. Further investigation into CBR SNPs in a larger adult sample is needed."}, {"pubmed": 26799497, "text": "association of SNPs in ABCB1 and CBR3 with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines."}, {"pubmed": 30096220, "text": "patients with advanced stage retinoblastoma had higher levels of PlncRNA-1 expression than patients with early stage retinoblastoma. There was an inverse correlation between PlncRNA-1 expression and CBR3 expression in retinoblastoma tissues, and PlncRNA-1 negatively regulated mRNA and protein expressions of CBR3."}, {"pubmed": 30125887, "text": "CBR3 730G>A is significantly associated with recurrence- free survival in patients who received intravesical chemotherapy with pirarubicin after complete transurethral resection."}, {"pubmed": 32945466, "text": "Long noncoding RNA CBR3 antisense RNA 1 promotes the aggressive phenotypes of nonsmallcell lung cancer by sponging microRNA5093p and competitively upregulating HDAC9 expression."}], "genomic_pos": {"chr": "21", "end": 36146562, "ensemblgene": "ENSG00000159231", "start": 36135079, "strand": 1}, "genomic_pos_hg19": {"chr": "21", "end": 37518864, "start": 37507210, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042376", "qualifier": "involved_in", "term": "phylloquinone catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050890", "pubmed": 23227193, "qualifier": "involved_in", "term": "cognition"}], "CC": [{"evidence": "HDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 22664934, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 18493841, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0000253", "qualifier": "enables", "term": "3-keto sterol reductase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004090", "qualifier": "enables", "term": "carbonyl reductase (NADPH) activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004090", "pubmed": 18493841, "qualifier": "enables", "term": "carbonyl reductase (NADPH) activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004090", "qualifier": "enables", "term": "carbonyl reductase (NADPH) activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [25910212, 31515488, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008753", "pubmed": 19841672, "qualifier": "enables", "term": "NADPH dehydrogenase (quinone) activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0070402", "pubmed": 18493841, "qualifier": "enables", "term": "NADPH binding"}]}, "homologene": {"genes": [[9544, 695769], [9598, 458533], [9606, 874], [9615, 487748], [9913, 516036], [10090, 109857], [10116, 304078]], "id": 20332}, "interpro": [{"desc": "Short-chain dehydrogenase/reductase SDR", "id": "IPR002347", "short_desc": "SDR_fam"}, {"desc": "Short-chain dehydrogenase/reductase, conserved site", "id": "IPR020904", "short_desc": "Sc_DH/Rdtase_CS"}, {"desc": "NAD(P)-binding domain superfamily", "id": "IPR036291", "short_desc": "NAD(P)-bd_dom_sf"}, {"desc": "Carbonyl reductase [NADPH] 1-like", "id": "IPR045313", "short_desc": "CBR1-like"}], "ipi": "IPI00290462", "map_location": "21q22.12", "name": "carbonyl reductase 3", "other_names": ["NADPH-dependent carbonyl reductase 3", "carbonyl reductase (NADPH) 3", "carbonyl reductase [NADPH] 3", "epididymis secretory protein Li 25", "quinone reductase CBR3", "short chain dehydrogenase/reductase family 21C member 2"], "pantherdb": {"HGNC": "1549", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1309992", "ortholog_type": "LDO", "panther_family": "PTHR43963", "taxid": 10090, "uniprot_kb": "Q8K354"}, {"RGD": "1309728", "ortholog_type": "LDO", "panther_family": "PTHR43963", "taxid": 10116, "uniprot_kb": "B2GV72"}, {"Ensembl": "ENSGALG00000016027", "ortholog_type": "O", "panther_family": "PTHR43963", "taxid": 9031, "uniprot_kb": "F1N8Y3"}, {"ZFIN": "ZDB-GENE-030131-9642", "ortholog_type": "O", "panther_family": "PTHR43963", "taxid": 7955, "uniprot_kb": "A8KC02"}, {"ZFIN": "ZDB-GENE-030902-2", "ortholog_type": "O", "panther_family": "PTHR43963", "taxid": 7955, "uniprot_kb": "Q7SYD0"}], "uniprot_kb": "O75828"}, "pathway": {"kegg": [{"id": "hsa00590", "name": "Arachidonic acid metabolism - Homo sapiens (human)"}, {"id": "hsa00980", "name": "Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}], "smpdb": {"id": "SMP00650", "name": "Doxorubicin Metabolism Pathway"}, "wikipathways": [{"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP2884", "name": "NRF2 pathway"}]}, "pdb": "2HRB", "pfam": "PF00106", "pharmgkb": "PA26122", "pharos": {"target_id": 13610, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF214769", "relationship": "is"}, {"id": "GNF246875", "relationship": "is"}, {"id": "GNF246876", "relationship": "is"}, {"id": "GNF246877", "relationship": "is"}, {"id": "GNF246878", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF161332", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF080432", "relationship": "is"}, {"id": "GNF080433", "relationship": "is"}, {"id": "GNF080434", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053737", "relationship": "is"}, {"id": "GNF058508", "relationship": "is"}, {"id": "GNF073741", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068289", "relationship": "is"}, {"id": "GNF068290", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF282868", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF283795", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF002152", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF285128", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094181", "relationship": "is"}, {"id": "GNF133838", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000021.9", "NC_060945.1", "NG_052818.1"], "protein": ["NP_001227.1", "XP_011528074.1", "XP_054180884.1"], "rna": ["NM_001236.4", "XM_011529772.3", "XM_054324909.1"], "translation": [{"protein": "XP_054180884.1", "rna": "XM_054324909.1"}, {"protein": "NP_001227.1", "rna": "NM_001236.4"}, {"protein": "XP_011528074.1", "rna": "XM_011529772.3"}]}, "reporter": {"HG-U133_Plus_2": "205379_at", "HG-U95Av2": "38172_at", "HTA-2_0": ["TC21000152.hg.1", "TC21000700.hg.1"], "HuEx-1_0": "3919834", "HuGene-1_1": "8068413", "HuGene-2_1": "16922495"}, "summary": "Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols.  The enzyme is classified as a monomeric NADPH-dependent oxidoreductase.  CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1. [provided by RefSeq, Jul 2008].", "symbol": "CBR3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413155"}, "unigene": "Hs.154510", "uniprot": {"Swiss-Prot": "O75828", "TrEMBL": "V9HW40"}, "wikipedia": {"url_stub": "CBR3"}}